Browsing by Author "Arbutina, Dragana (57194419213)"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Medical students’ knowledge level about Ebola; [Nivo znanja studenata medicine o Eboli](2015) ;Todorovic, Jovana (7003376825) ;Djuric, Dusan (35589783700) ;Marusic, Vuk (56411894600) ;Arbutina, Dragana (57194419213)Markovic Denic, Ljiljana (55944510900)The aim of this study was to evaluate the level of knowledge about Ebola viral disease among medical students. A cross-sectional survey was conducted among fourth-year and sixth-year students at the faculties of medicine in Belgrade and Kragujevac. Anonymous questionnaire was used containing data about social and demographic characteristics of students and data about epidemiological and clinical characteristics of Ebola, possibility of its prevention and protection of health care workers. A total of 858 medical students (401 fourth-year and 457 sixth-year students) filled in the questionnaire. Fourth-year students showed better knowledge about fruit bats as a natural reservoir of Ebola virus (p<0.001). They also showed better knowledge about transmission by direct or indirect contact with bodily fluids (91.1% vs. 79.7%, p<0.001) or sexual contact (43.9% vs. 30.8%, p<0.001), as well as that the infected person is not contagious during the incubation period (31.8% vs. 9.8%, p<0.001). Sixth-year students showed better knowledge about the first symptoms of Ebola, about therapy (69.1% vs. 80.3%, p<0.001) and about personal protective equipment for healthcare workers (88.9% vs. 93.1%, p=0.04). Fourth-year students expressed significantly higher interest in need for further education about Ebola viral disease (p=0.016). Given the current Ebola epidemic, which is still ongoing, as well as the possibility to introduce this disease into our country, there is a need for further education of medical students about Ebola. © 2015, Serbian Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Prognostic Value of Combined Hematological/Biochemical Indexes and Tumor Clinicopathologic Features in Colorectal Cancer Patients—A Pilot Single Center Study(2023) ;Cuk, Vladica (57213323195) ;Karamarkovic, Aleksandar (6507164080) ;Juloski, Jovan (57216998788) ;Arbutina, Dragana (57194419213) ;Radulovic, Radosav (57211460485) ;Milic, Ljiljana (37861945500) ;Kovacevic, Bojan (53984315400) ;De Luka, Silvio (56957018200)Grahovac, Jelena (57210167650)Colorectal cancer (CRC) is a significant public health problem. There is increasing evidence that the host’s immune response and nutritional status play a role in the development and progression of cancer. The aim of our study was to examine the prognostic value of clinical markers/indexes of inflammation, nutritional and pathohistological status in relation to overall survival and disease free-survival in CRC. The total number of CRC patients included in the study was 111 and they underwent laboratory analyses within a week before surgery. Detailed pathohistological analysis and laboratory parameters were part of the standard hospital pre-operative procedure. Medical data were collected from archived hospital data. Data on the exact date of death were obtained by inspecting the death registers for the territory of the Republic of Serbia. All parameters were analyzed in relation to the overall survival and survival period without disease relapse. The follow-up median was 42 (24−48) months. The patients with the III, IV and V degrees of the Clavien–Dindo classification had 2.609 (HR: 2.609; 95% CI: 1.437−4.737; p = 0.002) times higher risk of death. The modified Glasgow prognostic score (mGPS) 2 and higher lymph node ratio carried a 2.188 (HR: 2.188; 95% CI: 1.413−3.387; p < 0.001) and 6.862 (HR: 6.862; 95% CI: 1.635−28.808; p = 0.009) times higher risk of death in the postoperative period, respectively; the risk was 3.089 times higher (HR: 3.089; 95% CI: 1.447−6.593; p = 0.004) in patients with verified tumor deposits. The patients with tumor deposits had 1.888 (HR: 1.888; 95% CI: 1024−3481; p = 0.042) and 3.049 (HR: 3.049; 95% CI: 1.206−7.706; p = 0.018) times higher risk of disease recurrence, respectively. The emphasized peritumoral lymphocyte response reduced the risk of recurrence by 61% (HR: 0.391; 95% CI: 0.196−0.780; p = 0.005). Standard perioperative laboratory and pathohistological parameters, which do not present any additional cost for the health system, may provide information on the CRC patient outcome and lay the groundwork for a larger prospective examination. © 2023 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Prognostic Value of Combined Hematological/Biochemical Indexes and Tumor Clinicopathologic Features in Colorectal Cancer Patients—A Pilot Single Center Study(2023) ;Cuk, Vladica (57213323195) ;Karamarkovic, Aleksandar (6507164080) ;Juloski, Jovan (57216998788) ;Arbutina, Dragana (57194419213) ;Radulovic, Radosav (57211460485) ;Milic, Ljiljana (37861945500) ;Kovacevic, Bojan (53984315400) ;De Luka, Silvio (56957018200)Grahovac, Jelena (57210167650)Colorectal cancer (CRC) is a significant public health problem. There is increasing evidence that the host’s immune response and nutritional status play a role in the development and progression of cancer. The aim of our study was to examine the prognostic value of clinical markers/indexes of inflammation, nutritional and pathohistological status in relation to overall survival and disease free-survival in CRC. The total number of CRC patients included in the study was 111 and they underwent laboratory analyses within a week before surgery. Detailed pathohistological analysis and laboratory parameters were part of the standard hospital pre-operative procedure. Medical data were collected from archived hospital data. Data on the exact date of death were obtained by inspecting the death registers for the territory of the Republic of Serbia. All parameters were analyzed in relation to the overall survival and survival period without disease relapse. The follow-up median was 42 (24−48) months. The patients with the III, IV and V degrees of the Clavien–Dindo classification had 2.609 (HR: 2.609; 95% CI: 1.437−4.737; p = 0.002) times higher risk of death. The modified Glasgow prognostic score (mGPS) 2 and higher lymph node ratio carried a 2.188 (HR: 2.188; 95% CI: 1.413−3.387; p < 0.001) and 6.862 (HR: 6.862; 95% CI: 1.635−28.808; p = 0.009) times higher risk of death in the postoperative period, respectively; the risk was 3.089 times higher (HR: 3.089; 95% CI: 1.447−6.593; p = 0.004) in patients with verified tumor deposits. The patients with tumor deposits had 1.888 (HR: 1.888; 95% CI: 1024−3481; p = 0.042) and 3.049 (HR: 3.049; 95% CI: 1.206−7.706; p = 0.018) times higher risk of disease recurrence, respectively. The emphasized peritumoral lymphocyte response reduced the risk of recurrence by 61% (HR: 0.391; 95% CI: 0.196−0.780; p = 0.005). Standard perioperative laboratory and pathohistological parameters, which do not present any additional cost for the health system, may provide information on the CRC patient outcome and lay the groundwork for a larger prospective examination. © 2023 by the authors.
